Please use this identifier to cite or link to this item: http://ahro.austin.org.au/austinjspui/handle/1/16945
Title: Conversion of Bim-BH3 from Activator to Inhibitor of Bak through Structure-Based Design
Authors: Brouwer, Jason M;Lan, Ping;Cowan, Angus D;Birkinshaw, Richard W;van Delft, Mark F;Sleebs, Brad E;Robin, Adeline Y;Wardak, Ahmad;Tan, Iris K;Reljic, Boris;Lee, Erinna F;Fairlie, W Douglas;Call, Melissa J;Smith, Brian J;Dewson, Grant;Lessene, Guillaume;Colman, Peter M;Czabotar, Peter E
Issue Date: 16-Nov-2017
EDate: 2017-11-16
Citation: Molecular Cell 2017; 68(4): 659-672
Abstract: Certain BH3-only proteins transiently bind and activate Bak and Bax, initiating their oligomerization and the permeabilization of the mitochondrial outer membrane, a pivotal step in the mitochondrial pathway to apoptosis. Here we describe the first crystal structures of an activator BH3 peptide bound to Bak and illustrate their use in the design of BH3 derivatives capable of inhibiting human Bak on mitochondria. These BH3 derivatives compete for the activation site at the canonical groove, are the first engineered inhibitors of Bak activation, and support the role of key conformational transitions associated with Bak activation.
URI: http://ahro.austin.org.au/austinjspui/handle/1/16945
DOI: 10.1016/j.molcel.2017.11.001
PubMed URL: https://www.ncbi.nlm.nih.gov/pubmed/29149594
Type: Journal Article
Subjects: Bak
Bcl-2 family
Bim
apoptosis
inhibitor
non-natural amino acid
Appears in Collections:Journal articles

Files in This Item:
There are no files associated with this item.


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.